Search filters

List of works by Eva Carrasco

18F-fluoromisonidazole PET and Activity of Neoadjuvant Nintedanib in Early HER2-Negative Breast Cancer: A Window-of-Opportunity Randomized Trial.

scientific article published in September 2016

A phase Ib study of sonidegib (LDE225), an oral small molecule inhibitor of smoothened or Hedgehog pathway, in combination with docetaxel in triple negative advanced breast cancer patients: GEICAM/2012-12 (EDALINE) study

scientific article published on 09 June 2018

Clinical validation of the EndoPredict test in node-positive, chemotherapy-treated ER+/HER2- breast cancer patients: results from the GEICAM 9906 trial.

scientific article

Critically short telomeres and toxicity of chemotherapy in early breast cancer

scientific article

Defining breast cancer intrinsic subtypes by quantitative receptor expression

scientific article published on 23 April 2015

Evaluating the Applicability of Data-Driven Dietary Patterns to Independent Samples with a Focus on Measurement Tools for Pattern Similarity

scientific article

Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial

scientific article published on 29 June 2011

Gemcitabine plus vinorelbine versus vinorelbine monotherapy in patients with metastatic breast cancer previously treated with anthracyclines and taxanes: final results of the phase III Spanish Breast Cancer Research Group (GEICAM) trial

scientific article published on 01 March 2007

High Proliferation Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Early Breast Cancer

scientific article published on 19 January 2016

Lower Breast Cancer Risk among Women following the World Cancer Research Fund and American Institute for Cancer Research Lifestyle Recommendations: EpiGEICAM Case-Control Study.

scientific article published on 15 May 2015

PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.

scientific article

PAM50 proliferation score as a predictor of weekly paclitaxel benefit in breast cancer

scientific article published on 20 February 2013

Phase III trial evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for advanced breast cancer: the letrozole/fulvestrant and avastin (LEA) study.

scientific article published on 17 February 2015

Physical activity and breast cancer risk by pathological subtype

scientific article

Prognostic ability of EndoPredict compared to research-based versions of the PAM50 risk of recurrence (ROR) scores in node-positive, estrogen receptor-positive, and HER2-negative breast cancer. A GEICAM/9906 sub-study

scientific article published on 24 February 2016

Prognostic significance of progesterone receptor-positive tumor cells within immunohistochemically defined luminal A breast cancer

scientific article

Standard versus continuous administration of capecitabine in metastatic breast cancer (GEICAM/2009-05): a randomized, noninferiority phase II trial with a pharmacogenetic analysis

scientific article